Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection

New England Journal of Medicine

Volumn 338, Issue 19, 1998, Pages 1345-1351

  Hall, Colin D ^a   Dafni, Urania ^b   Simpson, David ^c   Clifford, David ^d   Wetherill, Patricia E ^e   Cohen, Bruce ^f   Mcarthur, Justin ^g   Hollander, Harry ^h   Yainnoutsos, Constantin ^b   Major, Eugene ⁱ   Millar, Linda ^j   Timpone, Joseph ^k  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^j FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^k DC General Hospital   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DIDANOSINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; ANEMIA; ARTICLE; BLOOD TOXICITY; BRAIN BIOPSY; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SAFETY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; THROMBOCYTOPENIA; TREATMENT FAILURE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; CYTARABINE; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, SPINAL; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 0344743110     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199805073381903     Document Type: Article

References (37)

1. Åström K-E, Mancall EL, Richardson EP Jr. Progressive multifocal leuko-encephalopathy: a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 1958;81:93-111.
2. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971;1:1257-60.
3. Brooks BR, Walker DL. Progressive multifocal leukoencephalopathy. Neurol Clin 1984;2:299-313.
4. Berger JR, Kaszovitz B, Post MJ, Dickinson G. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: a review of the literature with a report of sixteen cases. Ann Intern Med 1987;107:78-87.
5. Chappell ET, Guthrie BL, Orenstein J. The role of stereotactic biopsy in the management of HIV-related focal brain lesions. Neurosurgery 1992; 30:825-9.
6. Silver SA, Arthur RR, Erozan YS, Sherman ME, McArthur JC, Uematsu S. Diagnosis of progressive multifocal leukoencephalopathy by stereotactic brain biopsy utilizing immunohistochemistry and the polymerase chain reaction. Acta Cytol 1995;39:35-44.
7. Weber T, Turner RW, Frye S, et al. Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J Infect Dis 1994;169:1138-41.
8. McGuire D, Barhite S, Hollander H, Miles M. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy. Ann Neurol 1995;37:395-9.
9. Karahalios D, Breit R, Dal Canto MC, Levy RM. Progressive multifocal leukoencephalopathy in patients with HIV infection: lack of impact of early diagnosis by stereotactic brain biopsy. J Acquir Immune Defic Syndr 1992; 5:1030-8.
10. Hedley-White ET, Smith BP, Tyler HR, Peterson WP. Multifocal leukoencephalopathy with remission and five year survival. J Neuropathol Exp Neurol 1966;25:107-16.
11. Embrey JR, Silva FG, Helderman JH, Peters PC, Sagalowsky AI. Long-term survival and late development of bladder cancer in renal transplant patient with progressive multifocal leukoencephalopathy. J Urol 1988;139:580-1.
12. Berger JR, Mucke L. Prolonged survival and partial recovery in AIDS-associated progressive multifocal leukoencephalopathy. Neurology 1988; 38:1060-5.
13. Berger JR, Gallo BV, Concha M. Progressive multifocal leukoencephalopathy. In Berger JR, Levy RM, eds. AIDS and the nervous system. 2nd ed. Philadelphia: Lippincott-Raven, 1997:569-94.
14. Rand KH, Johnson KP, Rubenstein LJ, et al. Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: use of virus-containing cells in the urine to assess response to therapy. Ann Neurol 1977;1:458-62.
15. Wolinsky JS, Johnson KP, Rand K, Merigan TC. Progressive multifocal leukoencephalopathy: clinical pathological correlates and failure of a drug trial in two patients. Trans Am Neurol Assoc 1976;101:81-2.
16. Colosimo C, Lebon P, Martelli M, Tumminelli F, Mandelli F. Alpha-interferon therapy in a case of probable progressive multifocal leukoencephalopathy. Acta Neurol Belg 1992;92:24-9.
17. Steiger MJ, Tarnesby G, Gable S, McLaughlin J, Schapira AH. Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon. Ann Neurol 1993;33:407-11.
18. Berger J, Pall L, McArthur J, et al. A pilot study of recombinant alpha 2A interferon in the treatment of AIDS-related progressive multifocal leukoencephalopathy. Presented at the American Academy of Neurology Annual General Meeting, San Diego, Calif., May 3-9, 1992.
19. Counihan JT, Venna N, Craven D, Sabin D. Alpha interferon in AIDS-related progressive multifocal leukoencephalopathy. J NeuroAIDS 1996; 1(4):79.
20. Major EO. Polyomaviruses. In: Murray PR, ed. Manual of clinical microbiology. 6th ed. Washington, D.C.: American Society for Microbiology, 1995:1090-7.
21. Fiala M, Cone LA, Cohen N, et al. Responses of neurologic complications of AIDS to 3′-azido-3′-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl) guanine. 1. Clinical features. Rev Infect Dis 1988;10: 250-6.
22. Conway B, Halliday WC, Brunham RC. Human immunodeficiency virus-associated progressive multifocal leukoencephalopathy: apparent response to 3′-azido-3′-deoxythymidine. Rev Infect Dis 1990;12:479-82.
23. Britton CB, Romagnoli M, Sisti M, Powers JM. Progressive multifocal leukoencephalopathy: analysis of outcome and response to intrathecal ara-C in 26 patients. In: Program and abstract book: Neuroscience of HIV Infection, Basic and Clinical Frontiers 1992, Amsterdam, July 14-17, 1992:40. abstract.
24. Garrote FJ, Molina JA, Lacambra C, Mollejo M, Madero S, del Ser T. Ineficacia de la zidovudina (AZT) en la progresiva leucoencefalopatía multifocal (PLM) asociada al síndrome adquirida de inmunodeficiency (SIDA). Rev Clin Esp 1990;187:404-7.
25. Bauer WR, Turel AP Jr, Johnson KP. Progressive multifocal leukoencephalopathy and cytarabine: remission with treatment. JAMA 1973;226: 174-6.
26. Marriott PJ, O'Brien MD, Mackenzie IC, Janota I. Progressive multifocal leucoencephalopathy: remission with cytarabine. J Neurol Neurosurg Psychiatry 1975;38:205-9.
27. O'Riordan T, Daly PA, Hutchinson M, Shattock AG, Gardner SD. Progressive multifocal leukoencephalopathy - remission with cytarabine. J Infect 1990;20:51-4.
28. Portegies P, Algra PR, Hollak CE, et al. Response to cytarabine in progressive multifocal leucoencephalopathy in AIDS. Lancet 1991;337:680-1.
29. Nicoli F, Chave B, Peragut JC, Gastaut JL. Efficacy of cytarabine in progressive multifocal leucoencephalopathy in AIDS. Lancet 1992;339: 306.
30. Lidman C, Lindqvist L, Mathiesen T, Grane P. Progressive multifocal leukoencephalopathy in AIDS. AIDS 1991;5:1039-41.
31. Urtizberea JA, Flament-Saillour M, Clair B, de Truchis P. Cytarabine for progressive multifocal leucoencephalopathy (PML) in AIDS patients. In: Volume 1 of Abstract book: IXth International Conference on AIDS in affiliation with the IVth STD World Congress, Berlin, Germany, June 6-11, 1993. London: Wellcome Foundation, 1993:421. abstract.
32. Fong IW, Toma E, Canadian PML Study Group. The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Clin Infect Dis 1995;20:1305-10.
33. Zaky DA, Betts RF, Douglas RG Jr, Bengali K, Neil GL. Varicella-zoster virus and subcutaneous cytarabine: correlation of in vitro sensitivities to blood levels. Antimicrob Agents Chemother 1975;7:229-32.
34. Davis CM, VanDersarl JV, Coltman CA Jr. Failure of cytarabine in var icella-zoster infections. JAMA 1973;224:122-3.
35. Betts RF, Zaky DA, Douglas RG Jr, Royer G. Ineffectiveness of subcutaneous cytosine arabinoside in localized herpes zoster. Ann Intern Med 1975;82:778-83.
36. Elliot B, Aromin I, Flanigan T, Mileno M. Prolonged remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy. In: Program and abstracts of the 11th Conference on AIDS, Vancouver, B.C., July 7-12, 1996:222. abstract.
37. Mileno M, Tashima K, Farrar D, et al. Resolution of AIDS-related opportunistic infections with addition of protease inhibitor treatment. In: Program and abstracts of the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, D.C., January 22-26, 1997:129. abstract.